These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7923156)

  • 1. Cancers beget mutations versus mutations beget cancers.
    Prehn RT
    Cancer Res; 1994 Oct; 54(20):5296-300. PubMed ID: 7923156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aneuploidy, the somatic mutation that makes cancer a species of its own.
    Duesberg P; Rasnick D
    Cell Motil Cytoskeleton; 2000 Oct; 47(2):81-107. PubMed ID: 11013390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the steps that lead to cancer: replicative telomere erosion, aneuploidy and an epigenetic maturation arrest of tissue stem cells.
    Stindl R
    Med Hypotheses; 2008; 71(1):126-40. PubMed ID: 18294777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancers exhibit a mutator phenotype: clinical implications.
    Loeb LA; Bielas JH; Beckman RA
    Cancer Res; 2008 May; 68(10):3551-7; discussion 3557. PubMed ID: 18483233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumorigenesis: the adaptation of mammalian cells to sustained stress environment by epigenetic alterations and succeeding matched mutations.
    Karpinets TV; Foy BD
    Carcinogenesis; 2005 Aug; 26(8):1323-34. PubMed ID: 15802302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential sources of multiple mutations in human cancers.
    Christians FC; Newcomb TG; Loeb LA
    Prev Med; 1995 Jul; 24(4):329-32. PubMed ID: 7479621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation, imprinting and cancer.
    Plass C; Soloway PD
    Eur J Hum Genet; 2002 Jan; 10(1):6-16. PubMed ID: 11896451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutator phenotype in cancer: timing and perspectives.
    Bielas JH; Loeb LA
    Environ Mol Mutagen; 2005; 45(2-3):206-13. PubMed ID: 15672382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations and altered expression of the human cancer genes: what they tell us about causes.
    Devereux TR; Risinger JI; Barrett JC
    IARC Sci Publ; 1999; (146):19-42. PubMed ID: 10353382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA hypermethylation: when tumour suppressor genes go silent.
    Garinis GA; Patrinos GP; Spanakis NE; Menounos PG
    Hum Genet; 2002 Aug; 111(2):115-27. PubMed ID: 12189484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas.
    Liu FS; Kohler MF; Marks JR; Bast RC; Boyd J; Berchuck A
    Obstet Gynecol; 1994 Jan; 83(1):118-24. PubMed ID: 8272291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biology of solid cancers: breast cancer as an example. Second part: gene disregulation in breast cancer].
    Bièche I; Lidereau R
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(2):142-52. PubMed ID: 8690862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
    Havrilesky LJ; Alvarez AA; Whitaker RS; Marks JR; Berchuck A
    Gynecol Oncol; 2001 Dec; 83(3):491-500. PubMed ID: 11733961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic alterations and DNA repair in human carcinogenesis.
    Dixon K; Kopras E
    Semin Cancer Biol; 2004 Dec; 14(6):441-8. PubMed ID: 15489137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epigenome and cancer: new possibilities of cancer prevention and therapy?].
    Paluszczak J; Baer-Dubowska W
    Postepy Biochem; 2005; 51(3):244-50. PubMed ID: 16381168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours.
    Bignold LP
    Carcinogenesis; 2004 Mar; 25(3):299-307. PubMed ID: 14604890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The population dynamics of cancer: a Darwinian perspective.
    Vineis P; Berwick M
    Int J Epidemiol; 2006 Oct; 35(5):1151-9. PubMed ID: 16987840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of oncogenes and tumor suppressor genes in human malignancy.
    Spandidos DA; Liloglou T; Field JK
    Stem Cells; 1993 May; 11(3):194-8. PubMed ID: 8318905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.